Smile Invest’s first seven exits are no lucky feat – only strategy
Smile Invest’s bets are paying off as the Benelux private equity firm celebrates realising its first seven investments.
Smile Invest’s bets are paying off as the Benelux private equity firm celebrates realising its first seven investments.
The requirements and makings of the 2026 winner of the Best Venture Capital Deal – Technology Award.
Tailormade Logistics has completed a full management transition, with co-CEOs Kelly De Dijcker and Pieter Balcaen acquiring the remaining 25 percent stake from founder Bert Vandecaveye.
Dutch private equity firm, IceLake Capital, has acquired a majority stake in DKM Customs, a leading customs formalities specialist in Belgium.
Belgian specialist life sciences investment firm, Droia Ventures, is participating in a massive $152 million Series B funding round for Swiss-US biopharma company Vaderis Therapeutics.
The requirements and makings of the 2026 winner of the Best Venture Capital Deal – Technology Award.
Smile Invest’s bets are paying off as the Benelux private equity firm celebrates realising its first seven investments.
KooKoo co-founder Margot Desseyn fell in love with dealmaking because of the people; now she brings them together to discuss the strategies behind making these deals a success, and will join the M&A Community Belgium on 24 September 2026 in Antwerp to do it again.
During a recent M&A Community Belgium event, Syntagma Capital advisory board member and VIU founder Rudi Nerinckx revealed the top priorities on a carve-out HR agenda; from competency audits and TSAs to value creation plans.
Tailormade Logistics has completed a full management transition, with co-CEOs Kelly De Dijcker and Pieter Balcaen acquiring the remaining 25 percent stake from founder Bert Vandecaveye.
Dutch private equity firm, IceLake Capital, has acquired a majority stake in DKM Customs, a leading customs formalities specialist in Belgium.
Belgian specialist life sciences investment firm, Droia Ventures, is participating in a massive $152 million Series B funding round for Swiss-US biopharma company Vaderis Therapeutics.
Tailored W&I structures and synthetic warranties are changing the M&A landscape for Belgian entrepreneurs selling to private equity-backed consolidators, helping founders achieve a clean exit while maintaining deal certainty and transaction momentum.
M&A Community Belgium league tables reveal the PE firms topping Dealmakerdata.be this quarter and changing the ‘why’ behind dealmaking.
Co-founder Jorrit Willaert shares a preview of the Jurimesh W&I insurance guide and why it’s important for Belgian dealmakers.
Kjell Mortier has been appointed as an investment manager at PMV Life Sciences & Care.
Starting at the end of September, Jonah Israel will join KPMG Deal Advisory in Belgium as an M&A intern.
EY-Parthenon has appointed Leon Cheung as a senior consultant in data and AI for strategy and M&A.

